Our findings indicate a genetically protective effect of FGF20 on overall BC (OR 0.996, 95% CI: 0.993–1.000, P = .027), while FGF4 was associated with an increased risk of overall BC (OR 1.004, 95% CI: 1.001–1.007, P = .013). This evidence concerns the gene FGF4 and breast cancer.